Author

Chuanjie Chen

Institutions: Chinese Academy of Sciences, Shanghai Institute of Materia Medica

Observed institutions: Chinese Academy of Sciences, Shanghai Institute of Materia Medica, University of Chinese Academy of Sciences

ORCID: 0000-0001-9961-638X

Observed ORCID: 0000-0001-9961-638X

OpenAlex ID: A5025147235

Recent Advances in Pro-PROTAC Development to Address On-Target Off-Tumor Toxicity

2023 · Chuanjie Chen, Yiwen Yang, et al. · Journal of Medicinal Chemistry · 110

A rationally designed fluorescence probe achieves highly specific and long‐term detection of senescence in vitro and in vivo

2023 · Li Hu, Chanjuan Dong, et al. · Aging Cell · 37

Liver-targeting chimeras as a potential modality for the treatment of liver diseases

2024 · Chuanjie Chen, Yongzhang Pan, et al. · Journal of Controlled Release · 25

Abstract 7005: Discovery and characterization of DAC-1522, a novel Trop2-targeting degrader-antibody conjugate for precision oncology

2025 · Chuanjie Chen, Qianqian Shen, et al. · Cancer Research · 4

Abstract 2407: DAC-1522: A novel Trop2-targeting degrader-antibody conjugate for precision oncology.

2026 · Chuanjie Chen, Qianqian Shen, et al. · Cancer Research

Works count: 5

Citation count: 175

H-index: 3

I10-index: 3